Patients suffering in the long-stagnant therapeutic landscape of ulcerative colitis and Crohn’s disease gained encouragement with positive mid-stage results from Prometheus Biosciences Inc., which ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results